Delayed-onset complications of facial soft tissue augmentation with permanent fillers in 85 patients.
Jonathan A Kadouch, Daniel J Kadouch, Shai Fortuin, Leo van Rozelaar, Refaat B Karim, Rick Hoekzema
Index: Dermatol. Surg. 39(10) , 1474-85, (2013)
Full Text: HTML
Abstract
To evaluate factors influencing the onset and type of adverse events in patients injected with permanent fillers in the face and to propose a therapeutic strategy for these complications.A prospectively attained series of 85 patients with delayed-onset complications after facial injection with permanent fillers underwent clinical follow-up and treatment of the complications.Lag times until onset and type of delayed-onset complication varied according to filler material. In 28% (n = 24) of the cases, patients reported the onset of complications after dental procedures, additional injections with fillers, or other invasive treatments in the facial area. Forty-eight (57%) patients required invasive treatment. Abscess formation was significantly more frequent in patients with human immunodeficiency virus infection and facial lipoatrophy (p = .001).The intrinsic characteristics of the injected filler and the immune status of the patient play important roles in the diversity of time of onset and type of delayed-onset adverse events observed. It seems that invasive facial or oral procedures in the vicinity of filler depots can provoke such complications. We propose a strategy for treating these complications and advise great caution when using permanent filling agents.© 2013 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.
Related Compounds
Related Articles:
2014-05-01
[Plast. Reconstr. Surg. 133(5) , 628e-637e, (2014)]
2015-06-15
[Clin. Cancer Res. 21 , 2753-62, (2015)]
2014-12-01
[Infect. Immun. 82(12) , 5293-307, (2014)]
2014-04-01
[Urology 83(4) , 920-2, (2014)]
2014-05-01
[J. Urol. 191(5 Suppl) , 1628-33, (2014)]